What is NDC 31722-888?

31722-888 is the product NDC for Olmesartan medoxomil and hydrochlorothiazide, Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1 tablet, film coated, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

What is the active ingredient?

Olmesartan medoxomil, Hydrochlorothiazide.

Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Olmesartan medoxomil and hydrochlorothiazide?

59 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Olmesartan medoxomil and hydrochlorothiazide NDC 31722-888

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-888Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0888Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
31722-888-30	31722088830	30 TABLET, FILM COATED in 1 BOTTLE (31722-888-30)Marketed from Jul 25, 2025
31722-888-32	31722088832	10 BLISTER PACK in 1 CARTON (31722-888-32) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Jul 25, 2025
31722-888-90	31722088890	90 TABLET, FILM COATED in 1 BOTTLE (31722-888-90)Marketed from Jul 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olmesartan medoxomil and hydrochlorothiazide
Generic name (nonproprietary): olmesartan medoxomil and hydrochlorothiazide
Active ingredients: Olmesartan medoxomil — 40 mg/1Hydrochlorothiazide — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.NDC labeler code 31722
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209199
Marketing start: Jul 25, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 31722-888_3d401487-0f8f-9ee8-e063-6394a90ac68dSPL ID 3d401487-0f8f-9ee8-e063-6394a90ac68dSPL set ID d421f352-9500-4d3e-8bc3-0cdcc2050514RxCUI 403853, 403854, 403855UNII 6M97XTV3HD, 0J48LPH2THUPC 0331722888301, 0331722886307, 0331722887304
Pharmacologic class: Angiotensin 2 Receptor Blocker; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722088830 followed by a unit qualifier and the quantity

Package 31722-0888-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 26, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure [see Dosage and Administration ( 2 )]. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, in…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 31722-888

What is NDC 31722-888?: 31722-888 is the product NDC for Olmesartan medoxomil and hydrochlorothiazide, Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1 tablet, film coated, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Olmesartan medoxomil and hydrochlorothiazide.
What is the active ingredient?: Olmesartan medoxomil, Hydrochlorothiazide.
Who is the labeler?: Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Olmesartan medoxomil and hydrochlorothiazide?: 59 other product NDCs are listed under this name. See all Olmesartan medoxomil and hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Olmesartan medoxomil and hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Olmesartan medoxomil and hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4754	70518-4754-00
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	ScieGen Pharmaceuticals Inc	50228-342	50228-0342-1050228-0342-3050228-0342-90
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	ScieGen Pharmaceuticals Inc	50228-343	50228-0343-1050228-0343-3050228-0343-90
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	ScieGen Pharmaceuticals Inc	50228-344	50228-0344-1050228-0344-3050228-0344-90
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-056	84677-0056-1084677-0056-90
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-057	84677-0057-1084677-0057-90
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-058	84677-0058-1084677-0058-90
Olmesartan Medoxomil And Hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4577	70518-4577-00
Olmesartan Medoxomil and Hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-025	60290-0025-0160290-0025-0260290-0025-03+2 more
Olmesartan Medoxomil and Hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-026	60290-0026-0160290-0026-0260290-0026-03+2 more

All 60 Olmesartan medoxomil and hydrochlorothiazide NDCs

Other NDCs under ANDA 209199

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209199
Product	Strength	Form · route	Labeler	Product NDC
Olmesartan medoxomil and hydrochlorothiazide	Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-886
Olmesartan medoxomil and hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-887
Olmesartan medoxomil and hydrochlorothiazide	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4754